Jinhong Chang

Title: The Innovations of Jinhong Chang

Introduction

Jinhong Chang is a notable inventor based in Chalfont, PA, with a significant contribution to the field of glucosidase inhibition. He holds a total of nine patents, showcasing his dedication to advancing medical science and treatment methodologies.

Latest Patents

Among his latest patents are the development of 2,3-diacylated, 2- and 3-mono-acylated alkylated imino sugars that exhibit glucosidase inhibition. These innovative compounds are described as having a disease-modifying action in the treatment of diseases associated with glucosidase activity, including viral hemorrhagic fevers and other enveloped viruses. Additionally, he has developed pharmaceutical compositions comprising alkylated imino sugars derivatives that also target diseases involving glucosidase activity.

Career Highlights

Jinhong Chang has worked with esteemed institutions such as Drexel University and the Baruch S. Blumberg Institute. His work in these organizations has allowed him to collaborate with other experts in the field and contribute to significant advancements in medical research.

Collaborations

Some of his notable coworkers include Timothy Michael Block and Ju-Tao Guo, who have also made substantial contributions to the field of glucosidase research.

Conclusion

Jinhong Chang's innovative work in the development of glucosidase inhibitors highlights his commitment to addressing critical health challenges. His contributions continue to pave the way for new treatment options in the medical field.